Navigation Links
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
Date:5/16/2013

sults for a Phase 2 trial for ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, funded through a grant from USAMRMC.  The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development.  For additional information about AcelRx's clinical programs, please visit www.acelrx.com.

Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to the release and anticipated timing of additional NanoTab System clinical trial data, anticipated timing of completion of AcelRx Pharmaceuticals' current clinical trials, submission of the NDA, and the therapeutic potential of AcelRx Pharmaceuticals' product candidates.  These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties. AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the success, cost and timing of AcelRx Pharmaceuticals' product development activities and clinical trials; its ability to obtain and maintain regulatory approvals of its product candidates; the market potential for its product candidates; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' U.S. Securities and Exchange Commission filings, including its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2013.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

(Logo:  h
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
2. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
3. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
4. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
5. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
6. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
7. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
8. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. AcelRx Pharmaceuticals Provides Clinical Trial Updates
10. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
11. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... DUBAI , UAE, June 2, 2015 /PRNewswire/ ... to create the first, mainstream reporting standard for ... Principles. The next big step in CSR: The Islamic ... Launched only last month, the Islamic ... from across the Islamic world.  The latest members ...
(Date:6/1/2015)... -- LaunchPad Medical, LLC announced today that it has ... Corporation,s (NYSE: SYK ) bone adhesive technology, ... Under the terms of the agreement, LaunchPad has ... this technology which is covered by four issued ... from multiple pre-clinical animal studies.  LaunchPad will seek ...
(Date:6/1/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) ... focus on Omega-3 therapies for cardiovascular disease (CVD) ... financial results for the three months ended March ... in Canadian dollars unless otherwise stated. ... despite its limited financial resources," stated Mr. ...
Breaking Medicine Technology:Call for Partners: Islamic CSR 2LaunchPad Medical Executes Definitive License Agreement with Stryker for Novel Bone Adhesive Technology 2Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5
... Minn., May 29, 2012 /PRNewswire-iReach/ -- MD ... marker for ankylosing spondylitis (AS): HLA-B*2705 . The ... in flow cytometry, tissue staining and immunoprecipitation. ... (AS) is a chronc inflammatory arthritis. It is characterized ...
... Corp. today announced it is a founding member of ... HP for its server rack technology developed to the ... performance and reliability of HP ProLiant Generation 8 (Gen8). ... in the new HP ProLiant Gen8 servers, transforms data ...
Cached Medicine Technology:MD Bioproducts releases HLA-B27 subtype specific antibody. 2MD Bioproducts releases HLA-B27 subtype specific antibody. 3Rittal Corp. Joins the HP ProActive Insight Architecture Alliance 2
(Date:6/2/2015)... June 02, 2015 Amercanex, the ... Jim Miller to become Amercanex’s new Chief Technology ... marketplace in which cultivators, wholesale distributors and retail ... in a fully transparent intra-state market. , Jim ... the financial technology space, helping innovative technology companies ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Thermi, ... technology company has successfully transitioned into its new ... due to the company’s continued rapid worldwide expansion ... comprised of over 25 Thermi employees, including those ... development teams. , “As one of the fastest ...
(Date:6/2/2015)... Atlantic Spine Center , a ... three locations in New Jersey, announces the opening of ... facility is at 1045 Park Avenue (at East 86th ... can be arranged by calling 1-844-912-2406. , Dr. ... Center, has been a pioneer in the development of ...
(Date:6/2/2015)... North Vancouver, B.C., Canada (PRWEB) June 02, 2015 ... American publisher of audit, compliance and risk ... of a new online risk management effectiveness gap-improvement ... reduce the effect of uncertainty on objectives. Organizations ... but they improve their capabilities to do this ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Marcy Herrmann as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... organization exclusively for professional women, boasting more than 700,000 ... an honor to present Marcy with this distinction,” said ...
Breaking Medicine News(10 mins):Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2
... registration for the American Water Works Association,s Annual Conference and Exposition ... the conference and save up to $200 in registration fees. ... ... deadline for early registration for the American Water Works Association,s ...
... a plan to deal with market stress, he saidNEW ... deal with the stress of the market, psychiatrist and ... recent gathering of the Greenwich Roundtable, a non-profit research ... alternative investments.Kiev, president of Kiev Consulting, coaches institutional traders ...
... showed no benefit for brain-wasting disorders such as Creutzfeldt-Jakob ... drug quinacrine doesn,t prolong survival of patients with brain-wasting ... say. , Currently, there is no way to prevent ... -- an oral drug used to treat malaria and ...
... LONDON, March 11 , - With ... Smoking Day, three ,mini, entrepreneurs today went,head-to-head to win a GBP2,000 ... challenge, the school children faced their toughest,challenge yet when they presented ... smoking. , Shannon Stokes, 9, from Neith, ...
... attack: prevention has improved, mortality rates are down, hospitalisation ... from the Framingham Heart Study, which compared acute ... over four decades, has proposed an explanation for the ... stable rates of hospitalisation.(1) The study found that over ...
... sites offers recruitment and career opportunities to address ongoing needs., ... ... slowing economy and as unemployment climbs, many healthcare fields are still ... jobs in February, with a gain of 27,000. Job growth occurred ...
Cached Medicine News:Health News:ACE09 Early Registration Ends March 21 2Health News:Psychiatrist and Trading Coach Dr. Ari Kiev Addresses Greenwich Roundtable 2Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 2Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 3Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 4Health News:Explaining trends in heart attack 2Health News:Healthcare Industry Continues to Post Gains in a Down Economy 2
... The introduction of the AMO ... in Phaco technology; The combination of ... in complete control of fluidic conditions ... as the "smart Pump" orchestrates the ...
... the features of phaco systems costing much ... maintenance. Small, light and tough enough to ... cost reusable tubing kit can be auto-claved ... a price objection to purchasing a modern ...
Multiple Modulation Phaco (MMP) programmability with eight surgeon settings for maximum versatility. The combination of the peristaltic power balanced pump and the piezoelectric handpiece results in ...
The world's first and only laser surgical device combining irrigation and aspiration comfortable and precisely. This innovative combination is used for advanced small incision intraocular surgery....
Medicine Products: